Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$34.33 - $44.68 $1.02 Million - $1.33 Million
-29,737 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$40.81 - $53.88 $764,901 - $1.01 Million
-18,743 Reduced 38.66%
29,737 $1.28 Million
Q4 2020

Feb 16, 2021

SELL
$36.63 - $47.63 $256,410 - $333,410
-7,000 Reduced 12.62%
48,480 $2.12 Million
Q3 2020

Nov 04, 2020

BUY
$30.09 - $43.02 $207,621 - $296,838
6,900 Added 14.2%
55,480 $2.15 Million
Q2 2020

Jul 31, 2020

BUY
$27.76 - $33.42 $344,224 - $414,408
12,400 Added 34.27%
48,580 $1.57 Million
Q1 2020

May 08, 2020

SELL
$20.69 - $37.79 $33,104 - $60,464
-1,600 Reduced 4.24%
36,180 $1.08 Million
Q4 2019

Feb 11, 2020

SELL
$32.75 - $41.43 $6,550 - $8,286
-200 Reduced 0.53%
37,780 $1.3 Million
Q3 2019

Nov 01, 2019

SELL
$33.73 - $46.27 $337,299 - $462,700
-10,000 Reduced 20.84%
37,980 $1.28 Million
Q2 2019

Aug 13, 2019

BUY
$29.6 - $40.93 $841,912 - $1.16 Million
28,443 Added 145.59%
47,980 $1.96 Million
Q1 2019

May 13, 2019

BUY
$27.85 - $38.09 $5,570 - $7,618
200 Added 1.03%
19,537 $606,000
Q4 2018

Feb 14, 2019

SELL
$32.39 - $42.05 $67,500 - $87,632
-2,084 Reduced 9.73%
19,337 $699,000
Q3 2018

Nov 14, 2018

BUY
$35.69 - $47.65 $171,312 - $228,720
4,800 Added 28.88%
21,421 $835,000
Q2 2018

Aug 06, 2018

SELL
$28.41 - $42.41 $96,594 - $144,194
-3,400 Reduced 16.98%
16,621 $615,000
Q1 2018

May 03, 2018

BUY
$21.18 - $33.78 $424,044 - $676,309
20,021 New
20,021 $600,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.42B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.